Taken together, the expression of SR‐BI prevents thromboembolic disorders and other coagulopathy events in COVID‐19 through modulation of platelet function, coagulation, and fibrinolytic pathways (Figure 6). This evidence concerns the gene SCARB1 and COVID-19.